Press Review

Meet Rodney Turner, CEO of Multiplex Protein Analysis Company AYOXXA

BIO-Europe offers many opportunities. One of them is meeting with companies’ representatives to have a chat. In this context, we met with Rodney Turner, CEO of German company AYOXXA, which markets a technology for multiplex protein analysis.
Although it may sound complicated, the technology is quite straightforward. Simply put, it is the parallel analysis of multiple proteins from one single, very small sample.
Made for academics and researchers studying a variety of sample types – blood, serum, eye fluids, saliva, or cerebrospinal fluids – AYOXXA’s LUNARIS™ technology provides the opportunity to observe how the level of all signal proteins changes in response to a drug.

It also helps to understand how the immune system works and how inflammation develops in response to infections or other diseases.


Still have any questions? Ask us!

AYOXXA Newsletter

Be the first to know! Get regular news on AYOXXA and our products.

* The following fields are required for signing up our newsletter.

Connect with AYOXXA

Follow news and developments on these networks and platforms.